News &

October 28, 2019

Alexey Margolin, Ph.D.

Dr. Alexey Margolin is Chairman of the Board of Allena Pharmaceuticals, a public clinical stage pharmaceutical company, and previously served as CEO (2011-2019). Prior, he co-founded Alcresta Therapeutics, a medical device company focused on developing products for CF and other rare diseases; he served as CEO (2011-2014) and is currently on the board of directors. In 2008, Dr. Margolin co-founded Alnara Pharmaceuticals, and served as President and CEO until 2010, when the company was acquired by Eli Lilly. As Chief Scientific Officer for Altus Pharmaceuticals, he helped build a portfolio of products for rare diseases. Dr. Margolin is the author of more than 60 publications and an inventor on numerous patents.